WEE1 and Ewing sarcoma: Treatment of Ewing sarcoma cell lines with DDK inhibitors reduced the rate of DNA replication, prolonged the S-phase, induced aberrant mitotic progression, and demonstrated synergy with WEE1 inhibitors (3, 26, 27).